Bone Loss Completed Phase 4 Trials for Risedronic acid (DB00884)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00485953Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor TherapyPrevention
NCT00772395Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip ArthroplastyTreatment
NCT00869622Antiepileptic Drugs and Osteoporotic Prevention TrialPrevention